Fatty acid analogue N-Arachidonoyl taurine restores function of IKs channels with diverse long QT mutations

  1. Sara I Liin  Is a corresponding author
  2. Johan E Larsson
  3. Rene Barro-Soria
  4. Bo Hjorth Bentzen
  5. H Peter Larson  Is a corresponding author
  1. University of Miami, United States
  2. Linköping University, Sweden
  3. University of Copenhagen, Denmark

Abstract

About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.

Article and author information

Author details

  1. Sara I Liin

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    For correspondence
    sara.liin@liu.se
    Competing interests
    Sara I Liin, A patent application (62/032,739) based on these results has been submitted by the University of Miami with S.I.L. and H.P.L. identified as inventors.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8493-0114
  2. Johan E Larsson

    Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
    Competing interests
    No competing interests declared.
  3. Rene Barro-Soria

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  4. Bo Hjorth Bentzen

    The Danish Arrhythmia Research Centre, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
  5. H Peter Larson

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    For correspondence
    PLarsson@med.miami.edu
    Competing interests
    H Peter Larson, A patent application (62/032,739) based on these results has been submitted by the University of Miami with S.I.L. and H.P.L. identified as inventors.

Funding

National Institutes of Health (R01GM109762)

  • H Peter Larson

American Heart Association (14GRNT20380041)

  • H Peter Larson

Svenska Sällskapet för Medicinsk Forskning

  • Sara I Liin

Vetenskapsrådet (524-2011-6806)

  • Sara I Liin

Northwest Lions Foundation

  • Sara I Liin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Experiments were performed in strict accordance with the recommendations of The Linköping Animal Ethics Committee at Linköping University and The Animal Experiments Inspectorate under the Danish Ministry of Food, Agriculture and Fisheries. Protocols were approved by The Linköping Animal Ethics Committee at Linköping University (#53-13 ) and The Animal Experiments Inspectorate under the Danish Ministry of Food, Agriculture and Fisheries (University of Copenhagen; #2014-15-2934-01061).

Reviewing Editor

  1. Kenton J Swartz, National Institutes of Health, United States

Publication history

  1. Received: August 19, 2016
  2. Accepted: September 28, 2016
  3. Accepted Manuscript published: September 30, 2016 (version 1)
  4. Version of Record published: October 26, 2016 (version 2)
  5. Version of Record updated: November 1, 2016 (version 3)

Copyright

© 2016, Liin et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,111
    Page views
  • 281
    Downloads
  • 20
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sara I Liin
  2. Johan E Larsson
  3. Rene Barro-Soria
  4. Bo Hjorth Bentzen
  5. H Peter Larson
(2016)
Fatty acid analogue N-Arachidonoyl taurine restores function of IKs channels with diverse long QT mutations
eLife 5:e20272.
https://doi.org/10.7554/eLife.20272

Further reading

    1. Neuroscience
    2. Structural Biology and Molecular Biophysics
    Tianzhi Li, Qiqi Cheng ... Cong Ma
    Research Article

    Exocytosis of secretory vesicles requires the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins and small GTPase Rabs. As a Rab3/Rab27 effector protein on secretory vesicles, Rabphilin 3A was implicated to interact with SNAP-25 to regulate vesicle exocytosis in neurons and neuroendocrine cells, yet the underlying mechanism remains unclear. In this study, we have characterized the physiologically relevant binding sites between Rabphilin 3A and SNAP-25. We found that an intramolecular interplay between the N-terminal Rab-binding domain and C-terminal C2AB domain enables Rabphilin 3A to strongly bind the SNAP-25 N-peptide region via its C2B bottom α-helix. Disruption of this interaction significantly impaired docking and fusion of vesicles with the plasma membrane in rat PC12 cells. In addition, we found that this interaction allows Rabphilin 3A to accelerate SNARE complex assembly. Furthermore, we revealed that this interaction accelerates SNARE complex assembly via inducing a conformational switch from random coils to α-helical structure in the SNAP-25 SNARE motif. Altogether, our data suggest that the promotion of SNARE complex assembly by binding the C2B bottom α-helix of Rabphilin 3A to the N-peptide of SNAP-25 underlies a pre-fusion function of Rabphilin 3A in vesicle exocytosis.

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Lena Maria Muckenfuss, Anabel Carmen Migenda Herranz ... Martin Jinek
    Research Article Updated

    3′ end formation of most eukaryotic mRNAs is dependent on the assembly of a ~1.5 MDa multiprotein complex, that catalyzes the coupled reaction of pre-mRNA cleavage and polyadenylation. In mammals, the cleavage and polyadenylation specificity factor (CPSF) constitutes the core of the 3′ end processing machinery onto which the remaining factors, including cleavage stimulation factor (CstF) and poly(A) polymerase (PAP), assemble. These interactions are mediated by Fip1, a CPSF subunit characterized by high degree of intrinsic disorder. Here, we report two crystal structures revealing the interactions of human Fip1 (hFip1) with CPSF30 and CstF77. We demonstrate that CPSF contains two copies of hFip1, each binding to the zinc finger (ZF) domains 4 and 5 of CPSF30. Using polyadenylation assays we show that the two hFip1 copies are functionally redundant in recruiting one copy of PAP, thereby increasing the processivity of RNA polyadenylation. We further show that the interaction between hFip1 and CstF77 is mediated via a short motif in the N-terminal ‘acidic’ region of hFip1. In turn, CstF77 competitively inhibits CPSF-dependent PAP recruitment and 3′ polyadenylation. Taken together, these results provide a structural basis for the multivalent scaffolding and regulatory functions of hFip1 in 3′ end processing.